Morrison Foerster advised CSPC Megalith Biopharmaceutical Co., Ltd. on the deal. CSPC Megalith Biopharmaceutical Co., Ltd., a subsidiary of CSPC Pharmaceutical Group Limited (Stock code: 1093.HK),...
CSPC Megalith Biopharmaceutical’s License Agreement with Corbus Pharmaceuticals
CSPC Megalith Biopharmaceutical’s License Agreement with Elevation Oncology
Morrison Foerster advised CSPC Megalith Biopharmaceutical Co. on the deal. CSPC Megalith Biopharmaceutical Co., Ltd., a subsidiary of CSPC Pharmaceutical Group Limited (Stock code: 1093.HK) announced an...